About

Service

Advantage

Quarkmed Dynamics

Featured Services

Human Resources

Mail System

CTMS System

中EN

Grow Together Success Together

Infinite Faith in Permanence, Adhere to Result Orientation
Learn more

Pursue the Extreme and Exceed Expectations

We firmly believe that only by pursuing perfection can we exceed expectations

Search with Unbending Will and Keep Improving

Explore the new direction in medicine and adhere to high standards of service
Founded in 2011, Quarkmed is a professional clinical CRO (Contract Research Organization) service provider. Headquartered in Beijing, we maintain a nationwide presence with branches and representative offices in Shanghai, Guangzhou, Hangzhou, Chengdu, Wuhan, Zhengzhou, and Shenyang.
Our comprehensive service portfolio covers drug and device clinical research, data management and biostatistics, SMO, bioanalysis, and medical imaging. Additionally, we provide international registration services for markets in Europe, Australia, and North America.
Guided by the philosophy of technological innovation, Quarkmed actively explores the deep integration of Artificial Intelligence (AI) with clinical research, leading the digital transformation of clinical management.

MORE

Advantage

Nuclear Medicine Department

Quarkmed focuses on the fields of radiopharmaceuticals, radiotherapy and imaging, as well as isotope tracing, and provides professional and efficient clinical research services in nuclear medicine for radioactive diagnosis and treatment products at home and abroad.

Quarkmed is committed to leading the development of nuclear medicine clinical research in China with the ecological concept. Quarkmed inherits the core service concept of "Grow Together, Success After” by integrating domestic and foreign nuclear medicine resources in various fields. Quarkmed focuses on radiopharmaceuticals, radiation therapy and imaging, and isotope tracer and provide professional and efficient nuclear medicine clinical research services for domestic and oversea radioactive diagnosis and treatment products. From registration to clinical operation, further to commercialization, Quarkmed has become the most reliable partner for nuclear medicine clinical research services in China.

......

Tumour

The current situation of clinical trials of tumor drug research and development shows a trend of rapid development, diversification, complexity and refinement.

Research design and implementation require a high degree of professionalism and skills due to the complexity of tumor. Quarkmed has professional personnel and abundant project experience in the registration and application of tumor projects, clinical medicine, biostatistics and other fields. Combined with the AI data platform, Quarkmed accelerates the recruitment of subjects, solves problems such as follow-up difficulties, carefully design medical protocols, highly coordinated and detailed planning of clinical operations to ensure the quality and effectiveness of trials.

......

Cell and Gene Therapy

The research and development of cell and gene drugs is developing rapidly, and personalization, precision, multidisciplinary collaboration and big data application have become new research and development directions.

Quarkmed has been deeply engaged in the field of cell and gene therapy (CGT) for many years, and be capable of covering the registration and clinical trial services of the whole process from IND to NDA in the CGT field. In the past few years, Quarkmed has established cooperative relations with more than 100 relevant institutions in CGT field to reduce registration risks, write medical strategies, shorten project cycles, save R&D funds for customers, and contribute to the development of the CGT field from multiple dimensions.

......

Psychiatry and Neurology

The trend of research and development for psychotropic drugs shows the development of personalized treatment, new target exploration, comprehensive treatment and digital technology application.

Psychoneurotic clinical trials are difficult due to the complex etiology and symptoms of psychoneurotic diseases, and often lack of reliable biological markers. In addition, psychoneurotic trials involve sensitive issues such as patient privacy and ethics, which require strict compliance with ethical regulations. There are also challenges in patient screening, data collection and analysis, and interpretation of results, requiring strict control over the design and execution of trials to ensure the reliability and validity of study results.

......

Respiratory

The direction of research and development for respiratory drug shows a trend of precision, innovation and comprehensiveness, including the exploration of targeted therapy, new drug delivery systems, digital technology and other aspects.

Aspirated drugs require a special delivery system to ensure that the drugs may reach the intended site, so the design of medical protocols requires extremely high quality, which also increases the difficulty of clinical operation. Secondly, different patients have different reactions to drugs and aspiration technology, so it is necessary to conduct individualized evaluation and treatment for patients. According to the characteristics of different products, Quarkmed will develop detailed management plans to ensure that clinical projects are conducted scientifically and effectively.

......

Medical Devices

Lindao Medical, a subsidiary of Quark Medicine, insists on keeping up with the times and continuous innovation, and focuses deeply on CRO services in such fields as artificial intelligence, medical aesthetics, cardiovascular and cerebrovascular diseases, peripheral blood vessels, orthopedics, medical aesthetics, and ophthalmology. It provides full - chain services ranging from registration and declaration to clinical trials, offering professional and robust support to cooperative clients.

With the rapid development of medical device technology, Contract Research Organizations (CROs) for medical devices have become a highly - concerned hot area. Lindao Medical, a subsidiary of Quark Medicine, adheres to keeping pace with the times and continuous innovation, and delves deep into providing CRO services in fields such as artificial intelligence, medical aesthetics, cardiovascular and cerebrovascular diseases, peripheral blood vessels, orthopedics, medical aesthetics, and ophthalmology. It caters to the full - chain services from registration and application to clinical trials, offering professional and powerful support to its cooperative clients.

......

QuarkMed Services

Provide all-round services from registration declaration to post-marketing research, and have experience in various types of projects to provide customers with suitable solutions.

MORE

Medical equipment registration declaration

Clinical operations

Post-marketing research

Pharmacovigilance

clinical trial site management service

Medical affairs and strategies

Third-party audit

Data management statistics

Consultation services

Pharmacoeconomic evaluation

News

Learn the latest information of the pharmaceutical industry
172026-04

A Global First: The Dedicated Pediatric PET-CT Marks a Clinical Breakthrough

Recently, the worlds first 170ps-level dedicated pediatric all-digital PET/CT was unveiled, drawing significant attention. Specifically designed for pediatric p...

172026-04

Research Progress on Using 18F-FDG PET/CT Metabolic Parameters to Predict Molecular Subtypes of Diffuse Large B-Cell Lymphoma by the Team of Professor Yu-jing Hu from Hebei Provincial People's Hospital

Recently, the team led by Professor Yu-jing Hu from Hebei Provincial People’s Hospital published a study exploring the clinical value of 18F-FDG PET/CT me...

012025-12

Russian research team delves into crystallization of borosilicate glass to advance safe radioactive waste isolation

The Crystal Chemistry Laboratory of the Vernadsky Institute of Geochemistry and Analytical Chemistry, Russian Academy of Sciences, in collaboration with the Sou...

012025-12

Russia's nuclear power plant has completed cobalt-60 production ahead of schedule, expanding its medical isotope capabilities

Russias Leningrad, Kursk and Smolensk nuclear power plants (affiliated with Rosatom State Atomic Energy Corporation) have achieved remarkable results in cobalt-...

012025-12

Boron Neutron Capture Therapy: Sino-Russian Cooperation Advances Cancer Treatment

According to Marina Bikchurina, a senior researcher at the Institute of Nuclear Physics of the Siberian Branch of the Russian Academy of Sciences, more than 60 ...

212025-11

The UK launches targeted alpha therapy project to precisely destroy cancer cells using lead-212

Innovate UK recently announced a £9.9 million investment, combined with £8.9 million from industry partners, to jointly support a major project developing new c...

Contact Us

010-86469979

Address：Ping An Fortune Center, Lize Financial Business District of Beijing

Follow the Wechat official account

Follow the Wechat official account